202 related articles for article (PubMed ID: 24728097)
1. Association between serum tissue inhibitor of matrix metalloproteinase-1 levels and mortality in patients with severe brain trauma injury.
Lorente L; Martín MM; López P; Ramos L; Blanquer J; Cáceres JJ; Solé-Violán J; Solera J; Cabrera J; Argueso M; Ortiz R; Mora ML; Lubillo S; Jiménez A; Borreguero-León JM; González A; Orbe J; Rodríguez JA; Páramo JA
PLoS One; 2014; 9(4):e94370. PubMed ID: 24728097
[TBL] [Abstract][Full Text] [Related]
2. Serum tissue inhibitor of matrix metalloproteinase-1 levels are associated with mortality in patients with malignant middle cerebral artery infarction.
Lorente L; Martín MM; Ramos L; Cáceres JJ; Solé-Violán J; Argueso M; Jiménez A; Borreguero-León JM; Orbe J; Rodríguez JA; Páramo JA
BMC Neurol; 2015 Jul; 15():111. PubMed ID: 26162891
[TBL] [Abstract][Full Text] [Related]
3. Serum soluble CD40 Ligand levels are associated with severity and mortality of brain trauma injury patients.
Lorente L; Martín MM; González-Rivero AF; Ramos L; Argueso M; Cáceres JJ; Solé-Violán J; Serrano N; Rodríguez ST; Jiménez A; Borreguero-León JM
Thromb Res; 2014 Oct; 134(4):832-6. PubMed ID: 25123332
[TBL] [Abstract][Full Text] [Related]
4. Persistently high circulating tissue inhibitor of matrix metalloproteinase-1 levels in non-survivor brain trauma injury patients.
Lorente L; Martín MM; Ramos L; Argueso M; Cáceres JJ; Solé-Violán J; Jiménez A; Borreguero-León JM; González-Rivero AF; Orbe J; Rodríguez JA; Páramo JA
J Crit Care; 2019 Jun; 51():117-121. PubMed ID: 30802757
[TBL] [Abstract][Full Text] [Related]
5. Total antioxidant capacity is associated with mortality of patients with severe traumatic brain injury.
Lorente L; Martín MM; Almeida T; Abreu-González P; Ramos L; Argueso M; Riaño-Ruiz M; Solé-Violán J; Jiménez A
BMC Neurol; 2015 Jul; 15():115. PubMed ID: 26205136
[TBL] [Abstract][Full Text] [Related]
6. Association of sepsis-related mortality with early increase of TIMP-1/MMP-9 ratio.
Lorente L; Martín MM; Solé-Violán J; Blanquer J; Labarta L; Díaz C; Borreguero-León JM; Orbe J; Rodríguez JA; Jiménez A; Páramo JA
PLoS One; 2014; 9(4):e94318. PubMed ID: 24727739
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase-9, -10, and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsis.
Lorente L; Martín MM; Labarta L; Díaz C; Solé-Violán J; Blanquer J; Orbe J; Rodríguez JA; Jiménez A; Borreguero-León JM; Belmonte F; Medina JC; Llimiñana MC; Ferrer-Agüero JM; Ferreres J; Mora ML; Lubillo S; Sánchez M; Barrios Y; Sierra A; Páramo JA
Crit Care; 2009; 13(5):R158. PubMed ID: 19799791
[TBL] [Abstract][Full Text] [Related]
8. High Serum Tissue Inhibitor of Matrix Metalloproteinase-1 Levels and Mortality in Patients with Spontaneous Intracerebral Hemorrhage.
Lorente L; Martín MM; Ramos L; Argueso M; Cáceres JJ; Solé-Violán J; Jiménez A
World Neurosurg; 2020 Feb; 134():e476-e480. PubMed ID: 31669537
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of caspase-cleaved cytokeratin-18 in patients with severe traumatic brain injury are associated with mortality: a pilot study.
Lorente L; Martín MM; González-Rivero AF; Argueso M; Ramos L; Solé-Violán J; Cáceres JJ; Jiménez A; Borreguero-León JM
PLoS One; 2015; 10(3):e0121739. PubMed ID: 25822281
[TBL] [Abstract][Full Text] [Related]
10. Serum caspase-3 levels and mortality are associated in patients with severe traumatic brain injury.
Lorente L; Martín MM; Argueso M; Ramos L; Solé-Violán J; Riaño-Ruiz M; Jiménez A; Borreguero-León JM
BMC Neurol; 2015 Nov; 15():228. PubMed ID: 26545730
[TBL] [Abstract][Full Text] [Related]
11. Serum MMP-8 and TIMP-1 in critically ill patients with acute respiratory failure: TIMP-1 is associated with increased 90-day mortality.
Hästbacka J; Linko R; Tervahartiala T; Varpula T; Hovilehto S; Parviainen I; Vaara ST; Sorsa T; Pettilä V
Anesth Analg; 2014 Apr; 118(4):790-8. PubMed ID: 24651234
[TBL] [Abstract][Full Text] [Related]
12. Association between serum malondialdehyde levels and mortality in patients with severe brain trauma injury.
Lorente L; Martín MM; Abreu-González P; Ramos L; Argueso M; Cáceres JJ; Solé-Violán J; Lorenzo JM; Molina I; Jiménez A
J Neurotrauma; 2015 Jan; 32(1):1-6. PubMed ID: 25054973
[TBL] [Abstract][Full Text] [Related]
13. Serum substance P levels are associated with severity and mortality in patients with severe traumatic brain injury.
Lorente L; Martín MM; Almeida T; Hernández M; Ramos L; Argueso M; Cáceres JJ; Solé-Violán J; Jiménez A
Crit Care; 2015 Apr; 19(1):192. PubMed ID: 25928056
[TBL] [Abstract][Full Text] [Related]
14. High serum levels of tissue inhibitor of matrix metalloproteinase-1 during the first week of a malignant middle cerebral artery infarction in non-surviving patients.
Lorente L; Martín MM; Ramos L; Argueso M; Cáceres JJ; Solé-Violán J; Jiménez A; Borreguero-León JM; González-Rivero AF; Orbe J; Rodríguez JA; Páramo JA
BMC Neurol; 2019 Jul; 19(1):167. PubMed ID: 31319804
[TBL] [Abstract][Full Text] [Related]
15. The 372 T/C genetic polymorphism of TIMP-1 is associated with serum levels of TIMP-1 and survival in patients with severe sepsis.
Lorente L; Martín M; Plasencia F; Solé-Violán J; Blanquer J; Labarta L; Díaz C; Borreguero-León JM; Jiménez A; Páramo JA; Orbe J; Rodríguez JA; Salido E
Crit Care; 2013 May; 17(3):R94. PubMed ID: 23706069
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with moderate and severe traumatic brain injury.
Zheng K; Li C; Shan X; Liu H; Fan W; Wang Z; Zheng P
Neurol India; 2013; 61(6):606-9. PubMed ID: 24441327
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and prognostic value of neutrophil gelatinase-associated lipocalin, matrix metalloproteinase-9, and tissue inhibitor of matrix metalloproteinases-1 for sepsis in the Emergency Department: an observational study.
Wang M; Zhang Q; Zhao X; Dong G; Li C
Crit Care; 2014 Nov; 18(6):634. PubMed ID: 25407832
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase MMP-8, TIMP-1 and MMP-8/TIMP-1 ratio in plasma in methicillin-sensitive Staphylococcus aureus bacteremia.
Forsblom E; Tervahartiala T; Ruotsalainen E; Järvinen A; Sorsa T
PLoS One; 2021; 16(5):e0252046. PubMed ID: 34043679
[TBL] [Abstract][Full Text] [Related]
19. Association of Plasma Matrix Metalloproteinase and Tissue Inhibitors of Matrix Metalloproteinase Levels With Adverse Treatment Outcomes Among Patients With Pulmonary Tuberculosis.
Kumar NP; Moideen K; Nancy A; Viswanathan V; Thiruvengadam K; Sivakumar S; Hissar S; Nair D; Banurekha VV; Kornfeld H; Babu S
JAMA Netw Open; 2020 Dec; 3(12):e2027754. PubMed ID: 33258908
[TBL] [Abstract][Full Text] [Related]
20. Pre-treatment serum and plasma levels of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) in gastric cancer patients.
Mroczko B; Groblewska M; Łukaszewicz-Zajac M; Bandurski R; Kedra B; Szmitkowski M
Clin Chem Lab Med; 2009; 47(9):1133-9. PubMed ID: 19728856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
